Trade Grifols, S.A. - GRLS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.020027% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.002196% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Spain | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.75 |
| Open | 9.86 |
| 1-Year Change | -29.17% |
| Day's Range | 9.48 - 9.86 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 17, 2024 | 9.75 | 0.01 | 0.10% | 9.74 | 9.86 | 9.65 |
| Dec 16, 2024 | 9.65 | 0.24 | 2.55% | 9.41 | 9.86 | 9.37 |
| Dec 13, 2024 | 9.35 | 0.04 | 0.43% | 9.31 | 9.64 | 9.31 |
| Dec 12, 2024 | 9.58 | 0.35 | 3.79% | 9.23 | 9.89 | 9.23 |
| Dec 11, 2024 | 8.79 | -0.11 | -1.24% | 8.90 | 8.90 | 8.70 |
| Dec 10, 2024 | 8.84 | -0.01 | -0.11% | 8.85 | 8.92 | 8.77 |
| Dec 9, 2024 | 8.75 | 0.05 | 0.57% | 8.70 | 8.79 | 8.61 |
| Dec 6, 2024 | 8.59 | 0.00 | 0.00% | 8.59 | 8.72 | 8.54 |
| Dec 5, 2024 | 8.74 | 0.15 | 1.75% | 8.59 | 8.83 | 8.59 |
| Dec 4, 2024 | 8.63 | 0.13 | 1.53% | 8.50 | 8.71 | 8.27 |
| Dec 3, 2024 | 8.51 | 0.12 | 1.43% | 8.39 | 8.58 | 8.39 |
| Dec 2, 2024 | 8.33 | -0.17 | -2.00% | 8.50 | 8.57 | 8.25 |
| Nov 29, 2024 | 8.61 | 0.07 | 0.82% | 8.54 | 8.85 | 8.43 |
| Nov 28, 2024 | 8.55 | -0.94 | -9.91% | 9.49 | 9.59 | 8.28 |
| Nov 27, 2024 | 9.72 | -0.88 | -8.30% | 10.60 | 10.61 | 9.14 |
| Nov 26, 2024 | 10.65 | 0.09 | 0.85% | 10.56 | 10.70 | 10.42 |
| Nov 25, 2024 | 10.66 | 0.02 | 0.19% | 10.64 | 10.72 | 10.54 |
| Nov 22, 2024 | 10.59 | 0.19 | 1.83% | 10.40 | 10.64 | 10.38 |
| Nov 21, 2024 | 10.38 | -0.05 | -0.48% | 10.43 | 10.43 | 10.25 |
| Nov 20, 2024 | 10.42 | 0.10 | 0.97% | 10.32 | 10.46 | 10.28 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Grifols Company profile
About Grifols SA
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Grifols SA revenues decreased 8% to EUR4.93B. Net income before extraordinary items decreased 72% to EUR182.8M. Revenues reflect Bioscience segment decrease of 10% to EUR3.81B, United States/Canada segment decrease of 12% to EUR3.15B, Rest of the World segment decrease of 4% to EUR872.1M. Net income also reflects Selling/General/Admin. Expense - Balanci increase of 11% to EUR567.3M (expense).
Equity composition
12/11, 10% Stock dividend. 12/2011, Scrip Issue, 1 new share for every 10 shares held @ EUR0.1 (Factor: 1.1), 12/2012, Scrip Issue, 1 new B shares for every 20 B shares held (Factor: 1.05). 1/2016, 2-for-1 stock split (Factor: 2).
| Industry: | Biopharmaceuticals |
C/ Jesús y María, 6
BARCELONA
BARCELONA 08022
ES
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com